This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1977 Sep 17;2(6089):773-4.

doi: 10.1136/bmj.2.6089.773-c.

Interaction between azapropazone and warfarin

J C McElnay, P F D'Arcy

PMID: 912313
PMCID: PMC1632116
DOI: 10.1136/bmj.2.6089.773-c

Interaction between azapropazone and warfarin

J C McElnay et al. Br Med J. 1977.

. 1977 Sep 17;2(6089):773-4.

doi: 10.1136/bmj.2.6089.773-c.

Authors

J C McElnay, P F D'Arcy

PMID: 912313
PMCID: PMC1632116
DOI: 10.1136/bmj.2.6089.773-c

No abstract available

PubMed Disclaimer

Similar articles

Role of alpha-1 acid glycoprotein, albumin, and nonesterified fatty acids in serum binding of apazone and warfarin.
Urien S, Albengres E, Pinquier JL, Tillement JP. Urien S, et al. Clin Pharmacol Ther. 1986 Jun;39(6):683-9. doi: 10.1038/clpt.1986.119. Clin Pharmacol Ther. 1986. PMID: 3709033
Interaction between azapropazone and warfarin.
McElnay JC, D'Arcy PF. McElnay JC, et al. Experientia. 1978 Oct 15;34(10):1320-1. doi: 10.1007/BF01981445. Experientia. 1978. PMID: 738406
Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone.
Fehske KJ, Schläfer U, Wollert U, Müller WE. Fehske KJ, et al. Mol Pharmacol. 1982 Mar;21(2):387-93. Mol Pharmacol. 1982. PMID: 6808349
Impaired binding of drugs and endogenous ligands in renal diseases.
Gulyassy PF, Depner TA. Gulyassy PF, et al. Am J Kidney Dis. 1983 May;2(6):578-601. doi: 10.1016/s0272-6386(83)80038-9. Am J Kidney Dis. 1983. PMID: 6342372 Review. No abstract available.
The pharmacology and pharmacokinetics of azapropazone - a review.
Jones CJ. Jones CJ. Curr Med Res Opin. 1976;4(1):3-16. doi: 10.1185/03007997609109277. Curr Med Res Opin. 1976. PMID: 770078 Review.

See all similar articles

Cited by

Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs.
Lin JH, Cocchetto DM, Duggan DE. Lin JH, et al. Clin Pharmacokinet. 1987 Jun;12(6):402-32. doi: 10.2165/00003088-198712060-00002. Clin Pharmacokinet. 1987. PMID: 3301150 Review.
Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs.
Verbeeck RK, Blackburn JL, Loewen GR. Verbeeck RK, et al. Clin Pharmacokinet. 1983 Jul-Aug;8(4):297-331. doi: 10.2165/00003088-198308040-00003. Clin Pharmacokinet. 1983. PMID: 6352138 Review.
Drug interactions that matter. A critical reappraisal.
McInnes GT, Brodie MJ. McInnes GT, et al. Drugs. 1988 Jul;36(1):83-110. doi: 10.2165/00003495-198836010-00006. Drugs. 1988. PMID: 3063497 Review.
Azapropazone and warfarin.
Win N, Mitchell DC, Jones PA, French EA. Win N, et al. BMJ. 1991 Apr 20;302(6782):969-70. doi: 10.1136/bmj.302.6782.969-c. BMJ. 1991. PMID: 2032059 Free PMC article. No abstract available.
Azapropazone binding to human serum albumin.
Fehske KJ, Jähnchen E, Müller WE, Stillbauer A. Fehske KJ, et al. Naunyn Schmiedebergs Arch Pharmacol. 1980 Aug;313(2):159-63. doi: 10.1007/BF00498574. Naunyn Schmiedebergs Arch Pharmacol. 1980. PMID: 7422015

See all "Cited by" articles

References

1. Anal Biochem. 1968 Oct 10;26(1):151-73 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central